The effect of Cynara Scolymus on hyperlipidemia
Phase 3
- Conditions
- End stage renal disease.End stage kidney disease: in allograft failure NOS on dialysis or without dialysis or transplant , Renal retinitis , Uraemic: apoplexia+ , dementia+ , neuropathy+ , paralysis+ , pericarditisN17,N19
- Registration Number
- IRCT2017102022689N5
- Lead Sponsor
- Vice chancellor for research and technology, Tehran university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Entry criteria:History of hyperlipidemia in hemodialysis patient; with failure to control blood lipids (serum LDL =100 mg/dl );with Age over 18 and under 70 years old;with dialysis 2-3 time weekly every times for 3-4 hours;with The patient's willingness to participate in the research;having a case in considered nephrology center
without exclusion criteria;BMI less than 18;Artichoke use at least one month before the start of the study; unwillingness to continue to cooperate or traveling or death; pregnancy and lactation; the development of side effects of drug; lack of medication over a week.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum LDL concentration. Timepoint: At baseline and at the end of 4 and 8 weeks of study. Method of measurement: Special kits.
- Secondary Outcome Measures
Name Time Method